Asia-Pacific Vaccine Excellence Awards
Celebrating Asia-Pacific's Best in Vaccines
The Asia-Pacific Vaccine Excellence Awards seeks to give recognition to exceptional vaccine experts, organizations and technologies. Featuring leading vaccine manufacturers in the industry, along with the latest advances in technologies and best practices in vaccine manufacturing, the The Asia-Pacific Vaccine Excellence Awards applauds extraordinary leaders & trend-setters of today and inspires innovators of tomorrow!
1. What is the purpose of having the Asia-Pacific Vaccine Excellence Awards?
The Asia-Pacific Vaccine Excellence Awards (AVEA) seeks to recognize organizations within Asia Pacific region who have engaged in substantial efforts to innovate, optimize processes and uphold high level of efficacy, quality and safety in vaccine development and manufacturing. Nominations are free and open to all members of the industry. You don’t have to be a subscriber, an advertiser, a sponsor or a client of IMAPAC’s conferences to be nominated or to win.
2. What is the Judging Process for the awards?
Two rounds of call for nominations are conducted. Nominations are then passed on to the judging panel. The judging panel is made up of a team of 8 judges who assess the applications online, before making their final decisions on sub-category winners. Then sub-category winners/main category finalists will be announced to the industry and a voting process begins. The final main category winner will be determined via industry-wide voting over 2 weeks in and in the event of a tie, the judging panel intervenes to make the final decision based on the company’s track record over the past years.
3. How many years have the awards been held?
We have been hosting the Vaccines World Asia conference since 2019. Backed by overwhelming industry requests, we will be hosting the 1st Asia-Pacific Vaccines Excellence Awards in 2020.